Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Trial in Progress: Phase 3 MoonRISe-3 Study
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Nicholas J. Silvestri, MD
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Hans Katzberg, MD
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Diagnostic Advances in gMG: Effective Tools and Techniques
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
What’s New in Subconjunctival MIBS
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.